e-learning
resources
Glasgow 2004
Sunday 05.09.2004
Asthma and allergy: prevalence and risk factors
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Gender differences in the prevalence of severe asthma. Data from an island population database of high dose inhaled corticosteroid prescription
M. V. Balzan, S. Stuart, C. Nicky (Guardamangia, Malta)
Source:
Annual Congress 2004 - Asthma and allergy: prevalence and risk factors
Session:
Asthma and allergy: prevalence and risk factors
Session type:
Thematic Poster Session
Number:
930
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. V. Balzan, S. Stuart, C. Nicky (Guardamangia, Malta). Gender differences in the prevalence of severe asthma. Data from an island population database of high dose inhaled corticosteroid prescription. Eur Respir J 2004; 24: Suppl. 48, 930
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Genome-wide association study of asthma symptoms despite inhaled corticosteroids use in Dutch children.
Source: International Congress 2017 – Paediatric asthma: treatment modalities and behavioural issues
Year: 2017
Prevalence of oral corticosteroid use in the German severe asthma population
Source: ERJ Open Res, 5 (4) 00092-2019; 10.1183/23120541.00092-2019
Year: 2019
Predictors of excessive short-acting beta2-agonist use and asthma exacerbations: a retrospective analysis of a Polish prescription database.
Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Year: 2020
Changing prevalence of current asthma and inhaled corticosteroid treatment in the UK: population-based cohort 2006–2016
Source: Eur Respir J, 53 (4) 1802130; 10.1183/13993003.02130-2018
Year: 2019
Predictors of adherence to inhaled corticosteroids in children with asthma and their parents in a multi-ethnic population
Source: Annual Congress 2007 - Education, communication and quality of life in childhood asthma
Year: 2007
Recent trends in inhaled corticosteroid prescriptions and its impact on COPD management: an analysis of the KOLD/KOCOSS cohorts
Source: International Congress 2019 – COPD treatment: cohorts and real-world studies
Year: 2019
Changes in the use of anti-asthmatic medication in an international cohort
Source: Eur Respir J 2005; 26: 1047-1055
Year: 2005
Patterns of risk of death and asthma-related adverse outcomes in adult asthma patients receiving long-acting β
2
-agonist (LABA) therapy: results from the UK general practice research database (GPRD)
Source: Annual Congress 2009 - Asthma treatment and control strategies in primary care
Year: 2009
Meta-analysis of inhaled corticosteroids response in children with asthma.
Source: International Congress 2019 – Paediatric asthma: risk factors, biomarkers and the basics
Year: 2019
Genome-wide association study of inhaled corticosteroid response in African-admixed children with asthma.
Source: International Congress 2017 – Asthma: mechanisms and treatment
Year: 2017
Effect of maintenance oral corticosteroids on risk factors for frequent exacerbations in a severe adult asthma population
Source: Virtual Congress 2020 – Severe asthma phenotypes and outcomes
Year: 2020
Long-acting beta2-agonists in adult asthma and the pattern of risk of death and severe asthma outcomes: a study using the GPRD
Source: Eur Respir J 2010; 36: 494-502
Year: 2010
Pattern of asthma control and inhaled corticosteroid (ICS) use in an Australian asthma population
Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease
Year: 2013
Inhaled corticosteroid withdrawal may improve outcomes in elderly patients with COPD exacerbation: a nationwide database study
Source: ERJ Open Res, 6 (1) 00246-2019; 10.1183/23120541.00246-2019
Year: 2020
Genome-wide association study of asthma exacerbations in European children treated with inhaled corticosteroids
Source: International Congress 2017 – Asthma genetics and genomics in patients and populations
Year: 2017
Genome-wide association study of asthma exacerbations despite inhaled corticosteroid use
Source: Eur Respir J, 57 (5) 2003388; 10.1183/13993003.03388-2020
Year: 2021
Effect of 1 year treatment with inhaled corticosteroids with electronically assessed adherence on height growth in children with asthma
Source: International Congress 2015 – Paediatric asthma and allergy: asthma management
Year: 2015
Treatment with inhaled corticosteroids (ICS), smoking and asthma control in real clinical practice
Source: Annual Congress 2010 - Pharmacological treatment in primary care
Year: 2010
Barriers to adherence to inhaled corticosteroids in a high adherent population of children with asthma
Source: Annual Congress 2012 - Treating childhood asthma
Year: 2012
Mepolizumab in a population with severe eosinophilic asthma and corticosteroid dependence: results from a French early access programme
Source: Eur Respir J, 55 (6) 1902345; 10.1183/13993003.02345-2019
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept